South Dakota Investment Council Emergent Bio Solutions Inc. Transaction History

South Dakota Investment Council

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$33.11 - $55.01 $43,771 - $72,723	-1,322 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$50.07 - $66.05 $1.04 Million - $1.37 Million	-20,800 Reduced 94.02%	1,322 $66,000
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $110,838 - $156,058	1,400 Added 6.76%	22,122 $1.98 Million
Q3 2020 Nov 06, 2020	SELL	$81.91 - $134.94 $685,586 - $1.13 Million	-8,370 Reduced 28.77%	20,722 $2.14 Million
Q1 2020 May 11, 2020	SELL	$49.34 - $68.76 $1,381 - $1,925	-28 Reduced 0.1%	29,092 $1.68 Million
Q4 2019 Feb 11, 2020	BUY	$51.21 - $59.06 $53,258 - $61,422	1,040 Added 3.7%	29,120 $1.57 Million
Q3 2019 Nov 13, 2019	BUY	$40.6 - $57.2 $746,228 - $1.05 Million	18,380 Added 189.48%	28,080 $1.47 Million
Q2 2019 Aug 13, 2019	BUY	$39.92 - $53.86 $67,864 - $91,562	1,700 Added 21.25%	9,700 $469,000
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $416,400 - $532,080	8,000 New	8,000 $527,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.